BR0112830A - Medicamento destinado especialmente a combater as disfunções sexuais - Google Patents
Medicamento destinado especialmente a combater as disfunções sexuaisInfo
- Publication number
- BR0112830A BR0112830A BR0112830-2A BR0112830A BR0112830A BR 0112830 A BR0112830 A BR 0112830A BR 0112830 A BR0112830 A BR 0112830A BR 0112830 A BR0112830 A BR 0112830A
- Authority
- BR
- Brazil
- Prior art keywords
- medicinal product
- sexual dysfunction
- combat
- especially intended
- product especially
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
"MEDICAMENTO DESTINADO ESPECIALMENTE A COMBATER AS DISFUNçõES SEXUAIS". A presente invenção se refere a um medicamento compreendendo em associação, em um excipiente e/ou veículo farmacêutico, uma purina e um anti-inflamatório não esteróide (AINE). Os AINE potencializam a ação das purinas na prevenção ou tratamento das disfunções sexuais masculinas ou femininas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0010435A FR2812812B1 (fr) | 2000-08-08 | 2000-08-08 | Medicament destine notamment a combattre les dysfonctions sexuelles |
PCT/FR2001/002579 WO2002011665A2 (fr) | 2000-08-08 | 2001-08-08 | Association d'une purine et d'un ains pour le traitement des dysfonctions sexuelles |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0112830A true BR0112830A (pt) | 2003-06-24 |
Family
ID=8853401
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0112830-2A BR0112830A (pt) | 2000-08-08 | 2001-08-08 | Medicamento destinado especialmente a combater as disfunções sexuais |
BR0112908-2A BR0112908A (pt) | 2000-08-08 | 2001-08-08 | Utilização, em associação, de uma atividade de purina e de uma atividade de aine na preparação de um medicamento antitrombótico e/ou anti-inflamatório |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0112908-2A BR0112908A (pt) | 2000-08-08 | 2001-08-08 | Utilização, em associação, de uma atividade de purina e de uma atividade de aine na preparação de um medicamento antitrombótico e/ou anti-inflamatório |
Country Status (13)
Country | Link |
---|---|
US (2) | US20030139368A1 (pt) |
EP (2) | EP1309331A2 (pt) |
JP (2) | JP2004505897A (pt) |
CN (2) | CN1496265A (pt) |
AU (2) | AU2001284125A1 (pt) |
BR (2) | BR0112830A (pt) |
CA (2) | CA2419042A1 (pt) |
FR (1) | FR2812812B1 (pt) |
IL (2) | IL154215A0 (pt) |
NZ (1) | NZ523906A (pt) |
RU (2) | RU2003105600A (pt) |
WO (2) | WO2002011735A2 (pt) |
ZA (2) | ZA200300967B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005074946A1 (en) * | 2004-02-10 | 2005-08-18 | Adenobio N.V. | Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases |
NL1029244C2 (nl) * | 2005-06-10 | 2006-12-12 | Ronald Silfried Marlin | Middel ter vergroting van het mannelijk geslachtsorgaan. |
JP2008106064A (ja) * | 2006-09-28 | 2008-05-08 | Honda Trading Corp | t−PA亢進物質及びその製造方法 |
US20090197892A1 (en) * | 2007-08-21 | 2009-08-06 | Nawaz Ahmad | Anhydrous compositions useful for attaining enhanced sexual wellness |
GB201000196D0 (en) * | 2010-01-07 | 2010-02-24 | Galvez Julian M | Novel combination |
EP2583972B1 (en) * | 2010-06-18 | 2018-04-18 | Hayashibara Co., Ltd. | Therapeutic agent for inflammatory diseases containing adenosine n1-oxide as active ingredient |
US9132131B2 (en) | 2011-04-21 | 2015-09-15 | Saint Louis University | Use of adenosine A3 receptor agonists for treatment of neuropathic pain |
GB201300435D0 (en) | 2013-01-10 | 2013-02-27 | Medical Res Council | Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases |
MA40687A (fr) * | 2014-04-10 | 2017-03-28 | Ifom Fondazione St Firc Di Oncologia Molecolare | Méthodes et compositions de traitement de malformation vasculaire |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8379182A (en) * | 1981-06-04 | 1982-12-09 | Procter & Gamble Company, The | Composition of salicylates and purine derivatives |
US5242391A (en) * | 1990-04-25 | 1993-09-07 | Alza Corporation | Urethral insert for treatment of erectile dysfunction |
GB9608408D0 (en) * | 1996-04-23 | 1996-06-26 | Adams Michael A | Treatment of erectile dysfunction |
US5847003A (en) * | 1996-06-04 | 1998-12-08 | Avon Products, Inc. | Oxa acids and related compounds for treating skin conditions |
-
2000
- 2000-08-08 FR FR0010435A patent/FR2812812B1/fr not_active Expired - Fee Related
-
2001
- 2001-08-08 RU RU2003105600/15A patent/RU2003105600A/ru not_active Application Discontinuation
- 2001-08-08 EP EP01963079A patent/EP1309331A2/fr not_active Withdrawn
- 2001-08-08 IL IL15421501A patent/IL154215A0/xx unknown
- 2001-08-08 RU RU2003105601/15A patent/RU2003105601A/ru not_active Application Discontinuation
- 2001-08-08 AU AU2001284125A patent/AU2001284125A1/en not_active Abandoned
- 2001-08-08 IL IL15421601A patent/IL154216A0/xx unknown
- 2001-08-08 ZA ZA200300967A patent/ZA200300967B/en unknown
- 2001-08-08 JP JP2002517003A patent/JP2004505897A/ja active Pending
- 2001-08-08 AU AU2001284126A patent/AU2001284126A1/en not_active Abandoned
- 2001-08-08 CN CNA018170404A patent/CN1496265A/zh active Pending
- 2001-08-08 NZ NZ523906A patent/NZ523906A/en unknown
- 2001-08-08 JP JP2002517071A patent/JP2004505921A/ja active Pending
- 2001-08-08 WO PCT/FR2001/002580 patent/WO2002011735A2/fr active IP Right Grant
- 2001-08-08 CA CA002419042A patent/CA2419042A1/fr not_active Abandoned
- 2001-08-08 CA CA002420066A patent/CA2420066A1/fr not_active Abandoned
- 2001-08-08 BR BR0112830-2A patent/BR0112830A/pt not_active IP Right Cessation
- 2001-08-08 CN CNA018170315A patent/CN1468104A/zh active Pending
- 2001-08-08 ZA ZA200300966A patent/ZA200300966B/en unknown
- 2001-08-08 EP EP01963080A patent/EP1311273A2/fr not_active Withdrawn
- 2001-08-08 BR BR0112908-2A patent/BR0112908A/pt not_active IP Right Cessation
- 2001-08-08 WO PCT/FR2001/002579 patent/WO2002011665A2/fr not_active Application Discontinuation
-
2003
- 2003-02-07 US US10/360,280 patent/US20030139368A1/en not_active Abandoned
- 2003-02-07 US US10/360,354 patent/US20030139371A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002011665A2 (fr) | 2002-02-14 |
WO2002011665A3 (fr) | 2002-08-08 |
JP2004505897A (ja) | 2004-02-26 |
US20030139371A1 (en) | 2003-07-24 |
BR0112908A (pt) | 2003-06-24 |
CA2420066A1 (fr) | 2002-02-14 |
CA2419042A1 (fr) | 2002-02-14 |
IL154215A0 (en) | 2003-07-31 |
CN1468104A (zh) | 2004-01-14 |
US20030139368A1 (en) | 2003-07-24 |
EP1311273A2 (fr) | 2003-05-21 |
WO2002011735A2 (fr) | 2002-02-14 |
NZ523906A (en) | 2004-09-24 |
AU2001284126A1 (en) | 2002-02-18 |
FR2812812A1 (fr) | 2002-02-15 |
JP2004505921A (ja) | 2004-02-26 |
ZA200300966B (en) | 2004-02-09 |
IL154216A0 (en) | 2003-07-31 |
WO2002011735A3 (fr) | 2002-08-08 |
EP1309331A2 (fr) | 2003-05-14 |
FR2812812B1 (fr) | 2002-10-11 |
RU2003105600A (ru) | 2004-08-10 |
CN1496265A (zh) | 2004-05-12 |
RU2003105601A (ru) | 2004-09-10 |
AU2001284125A1 (en) | 2002-02-18 |
ZA200300967B (en) | 2004-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300889I2 (nl) | Trifluridine in combinatie met tipiracilhydrochloride | |
BR0113927A (pt) | Processos para retardar a recorrência dos sintomas de herpes vìrus | |
MX9307885A (es) | Aplicacion de la carbamzaepina y oxcarbazepian para la obtencion de medicamentos para el tratamiento de la enfermedad de parkinson y los sindromes parkinsonianos. | |
HK1079445A1 (en) | Ophthalmological use of roflumilast for the treatment of diseases of the eye | |
TW200616640A (en) | Novel pharmaceutical formulations of active principles | |
BRPI0310021B8 (pt) | composição farmacêutica compreendendo 4-[[4-[(2,4,6-trimetilfenil)amino]-2-pirimidinil]amino]benzonitrilo ou um sal de adição farmaceuticamente aceitável de mesmo | |
BRPI0518266A2 (pt) | medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular | |
UY27186A1 (es) | Formulación farmacéutica | |
CO5170471A1 (es) | Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio | |
KR930007441A (ko) | 의약품 | |
HK1087336A1 (en) | Pharmaceutical composition comprising lumiracoxib | |
UY27296A1 (es) | Composición farmacéutica que contiene mosaprida y pancreatina | |
WO1995030423A3 (en) | Cancer treatment and metastasis prevention | |
IL158668A0 (en) | Deuterated 3-piperidinopropiophenone and medicaments containing said compounds | |
AR035652A1 (es) | Una composicion nutricional, util para combatir la infeccion en el tracto gastrointestinal causada por organismos tipo helicobacter, el uso de dicha composicion para la preparacion de medicamentos, o productos alimenticios y el procedimiento para preparar dicha composicion | |
AR039633A2 (es) | Uso de un compuesto tipo cabergolina para preparar un medicamento para el tratamiento de la fibromialgia y el sindrome de fatiga cronica | |
BR0112830A (pt) | Medicamento destinado especialmente a combater as disfunções sexuais | |
BR0013719A (pt) | Dosagem oral de liberaçâo controlada, apropriada para administração oral | |
AR035946A1 (es) | Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos | |
AR036877A1 (es) | Formulacion farmaceutica | |
BR0207866A (pt) | Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna | |
BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
AR039162A1 (es) | Formulaciones de venlafaxina de liberacion extendida | |
AR024981A1 (es) | Composicion para la prevencion y el tratamiento de las disfunciones y enfermedades del rinon | |
ECSP066836A (es) | Piperazinas derivadas de úrea para el tratamiento de la endometrosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A,6AE7A ANUIDADE |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008. |